Neither mechanism directly stimulates insulin secretion in a glucose-independent manner, making the combination inherently safer regarding hypoglycaemia compared to sulphonylureas or insulin
In the GGIT, both the increase in ISR AUC over the 512 mmol/l glucose interval (AUC 512mmol ) from baseline to end of treatment and the increase in the corresponding slope of the ISR vs glucose curve (doseresponse relationship) were significantly greater in the semaglutide group than in the placebo group (ETR [95% CI]: 2.45 [2.16, 2.77] and 2.78 [2.44, 3.16], respectively
He Z, Tabe AN, Rana S, King K
753483) and were maintained at 37 C in a humidified incubator with 5% CO 2
If your licensed provider determines that this program is not clinically appropriate for you after reviewing your health intake, you will receive a full refund